NCT03105921View on ClinicalTrials.gov

Irreversible Electroporation (NanoKnife) for the Treatment of Pancreatic Adenocarcinoma

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 24, 2014

Primary Completion Date

April 1, 2021

Study Completion Date

April 1, 2021

Conditions
Pancreatic AdenocarcinomaInterventional Imaging
Interventions
DEVICE

NanoKnife

The aim of the treatment is to sourround the tumour with two to six needles and to deliver a very high voltage current (3000 volts in 70 to 80 microseconds pulses) by a generator synchronized with an electrocardiogram.

Trial Locations (1)

86000

CHU Poitiers, Poitiers

All Listed Sponsors
lead

Poitiers University Hospital

OTHER

NCT03105921 - Irreversible Electroporation (NanoKnife) for the Treatment of Pancreatic Adenocarcinoma | Biotech Hunter | Biotech Hunter